Recently tremendous progress has been made in studying choroid plexus (CP) physiology and pathophysiology; and correcting several misconceptions about the CP. Specifically, the details of how CP, a locus of the blood-CSF barrier (BCSFB), secretes and purifies CSF, generates intracranial pressure (ICP), maintains CSF ion homeostasis, and provides micronutrients, proteins and hormones for neuronal and glial development, maintenance and function, are being understood on a molecular level. Unequivocal evidence that the CP secretory epithelium is the predominant supplier of CSF for the ventricles comes from multiple lines: uptake kinetics of tracer Cl permeation (high permeability coefficients) into the cerebroventricles, CSF sampling from several different in vivo and in vitro CP preparations, CP hyperplasia that increases CSF formation and ICP; and in vitro analysis of CP ability to transport molecules (with expected directionality) and actively secrete fluid against an hydrostatic fluid column. Furthermore, clinical support for this CP-CSF model comes from neurosurgical procedures to remove lateral ventricle CPs in hydrocephalic children to reduce CSF formation, thereby relieving elevated ICP. In terms of micronutrient transport, ascorbic acid, folate and other essential factors are transported by specific (cloned) carriers across CP into ventricular CSF, from which they penetrate across the ependyma and pia mater deeply into the brain to support its viability and function. Without these choroidal functions, severe neurological disease and even death can occur. In terms of efflux or clearance transport, the active carriers (many of which have been cloned and expressed) in the CP basolateral and apical membranes perform regulatory removal of some metabolites (e.g. choline) and certain drugs (e.g. antibiotics like penicillin) from CSF, thus reducing agents such as penicillin to sub-therapeutic levels. Altogether, these multiple transport and secretory functions in CP support CSF homeostasis and fluid dynamics essential for brain function.
Introduction
The purposes of this review are to summarize newer information about the structure and function of the adult choroid plexus (CP), focusing on issues with clinical relevance, and to correct several misconceptions in the literature. Particularly, we stress the predominant role of the CP in secreting ventricular cerebrospinal fluid (CSF) that maintains ICP and bulk flow down the neuraxis into the subarachnoid space. Our emphasis will be on humans greater than age two since the function of the CP in younger children awaits elucidation (Bateman and Brown, 2012) . In this section, we underscore key points expanded upon in the body of the text.
The living anatomy of the CP is very revealing. As aptly remarked by Wei Zheng, "In the human brain at autopsy during which the CSF is usually completely drained, the choroid plexus can be seen to extend along the floor of the lateral ventricles, hang down from the roof of the third ventricle, and overly the roof of the fourth ventricle. The size of the tissue in one ventricle when in a dry, condensed state appears to be nothing more than that of an index finger. These autopsy impressions, which have over the years become the popular perception among many neuropathologists, can be dreadfully misleading and may lead to misjudgments of the function of this tissue. Recent advances in technology have enabled a micro-video probe to be inserted directly into the lateral ventricles. The vivid images illustrate that the live choroid plexus pervades the ventricles, stretching and pulsating in concert with the heart pulse. To better understand this, it may be helpful to make an analogy between the choroid plexus and a fishnet. The fishnet occupies barely one corner of the fishing boat; yet upon spreading in the water, it extends to cover a large area. Likewise, in the life situation where the brain ventricles are full of CSF, the choroid plexus expands to fill nearly all the cerebral ventricles. Unlike the fishnet, however, the plexus tissue possesses well-developed brush-type borders, i.e., microvilli, on the apical epithelial surface. These brush borders further protrude into the CSF and increase the choroidal epithelial surface area, enabling rapid and efficient delivery of the CSF as well as other material included with the CSF secretion" (Zheng and Chodobski, 2005) .
Notwithstanding recent definitive data, reference is still made (Tang et al., 2014) to older erroneous histological data claiming that the CP apical surface area is small and therefore not physiologically important for mediating brain-wide molecular distribution (Pardridge, 2011) . However, in fact, as discussed below CP surface area is substantial, 25 to 50% the size of the inner capillary surface area of the brain. This provides an enormous surface area for performing a myriad of choroidal transport functions. Moreover, the large surface area of brain capillaries and CP epithelial cells also allows water to diffuse freely and bidirectionally between blood, brain and CSF. Sweet et al. (1950) first showed this phenomenon in humans. Subsequently Oldendorf demonstrated in rats that greater than 50% of plasma water exchanges with the water of brain and CSF in a single pass of blood through the brain (Oldendorf, 1970) . The exact mechanism of this huge bidirectional flux of water through the brain capillaries and CP is unknown since in adults there are no obvious aquaporins in brain capillary endothelium or on the basal side of the choroidal epithelium (Speake et al., 2003) . We also know that secretion of CSF is volumetrically b1/100 that of CNS water diffusional exchange (Bateman and Brown, 2012; Brinker et al., 2014) . The preponderance of CSF is formed by CP and consists of salts, micronutrient vitamins, secreted proteins, hormones and water pulled along passively to maintain osmotic equilibrium, as described below.
One group states that CP does not produce CSF (Oreskovic and Klarica, 2010) , a result inconsistent with over 60 years of data obtained for animals and humans. Among the multiple experiments countering this view, we cite three recent examples. First, in accordance with the most powerful of the causality arguments of John Stuart Mill, the method of commitment variation, often termed dose-response causality in pharmacology, one would predict that more CSF would be produced in CP hyperplasia if the CP produces CSF. As part of a definitive review of CP hyperplasia cases, Hallaert and colleagues present as an example (Hallaert et al., 2012) , a very wellstudied case of a 3-year-old child with communicating hydrocephalus in which the lateral CP, but not the third and fourth ventricular CPs, were enlarged on MRI due to a genetic defect; with the external drainage system at the level of the foramen of Monroe, this 10 kg child copiously produced 2 l of CSF per day! On removal of the two enlarged lateral plexuses, the histological appearance of the tissue was normal and the child's CSF overproduction was prevented. There is no doubt that her CP secreted CSF in this case. Similarly, in many other cases of increased ICP (e.g., hydrocephalus) due to relative or absolute overproduction of CSF, as discussed below, removal of the lateral CP tissues is beneficial by substantially lowering the ICP.
Secondly, for decades we have also known that the CP contains multiple transporters capable of transferring Na + , Cl − , and HCO 3 − from blood into CSF across the CP -a typical secretory epithelium. Recently, in one example of a sophisticated study in mice (Kao et al., 2011) , the investigators knocked out the CP transporter sla4a5 that transports NaHCO 3 into CSF. Sla4a5 exists only on the apical surface of CP, apparently nowhere else in the CNS. These sla4a5 knockout (KO) mice had a ventricular volume and CSF pressure only~25% of normal. Moreover, their CSF had a lower HCO 3 − concentration, as expected. This study clearly showed that the CP, with the aid of sla4a5 and other ion transporters, produces HCO 3 − -containing CSF. And thirdly, the CP epithelial monolayer in an in vitro trans-well actively transports not only vitamin C (Angelow et al., 2003) but also "CSF" from the basal to the apical (ventricular) side against a considerable hydrostatic pressure gradient (Hakvoort et al., 1998) . Such fluid pumping against pressure clearly mimics the in vivo situation of elevated ICP in hydrocephalus.
Another set of concepts needing revision is that drugs and nutrients pass into and out of CSF mainly by passive forces largely dependent on molecular weight, ionic charge and lipid solubility; and do not penetrate deeply into the substance of the brain from CSF (Nagaraja et al., 2005; Pardridge, 2011 Pardridge, , 2012 . These concepts need qualification in order to promote precise understanding and sound therapeutic regimens, as discussed below.
Anatomy of choroid plexus: structural-functional relationships
Choroid plexus ultrastructure is similar in the lateral, third and fourth ventricles. There is a vascular network surrounded by a single layer of roughly cuboidal epithelial cells that are joined by tight junctions and make up the blood-CSF barrier ( Fig. 1) (Smith et al., 2004) . The vascular endothelial cells differ from those forming the bloodbrain barrier in being fenestrated (Wolburg and Paulus, 2010) . Evidence indicates that endothelial fenestrations, in the kidney and CP, facilitate the movement of fluid out of the capillaries (Ballermann and Stan, 2007) . Between the endothelium and the epithelium is an area of stroma. The choroidal epithelial cells, linked by tight junctions at the apical, CSF-facing pole of the lateral membrane (thus accounting for the blood-CSF barrier), have an apical brush border membrane and many basolateral interdigitations (Wolburg and Paulus, 2010) .
The choroid plexus epithelium has a large mitochondrial content that is~12-15% of adult cell volume (Cornford et al., 1997) , consistent with the high energy demand for transepithelial transport. Numerous mitochondria are close to the apical brush border, presumably for energizing a plethora of secretory mechanisms [e.g., for the peptides fibroblast growth factor-2, arginine vasopressin & insulin-like growth factor-II (Chodobski and Szmydynger-Chodobska, 2001; Walter et al., 1999) , and the proteins transthyretin, cystatin C & insulin-like growth factor binding protein-2 (Aldred et al., 1995) ]; as well as reabsorptive transporters that regulate CSF concentrations of certain substances [e.g., for iodide, potassium & amino acids] (Davson et al., 1987) . Thus the brush border is studded with an array of diversely-functioning transporters that bidirectionally move various ions and molecules between blood and ventricular CSF.
Human CP expresses a wide range of transporters (Damkier et al., 2013) . Many of these are asymmetrically distributed between apical and basolateral membranes indicating involvement in vectorial transport (Spector and Johanson, 2010) . The secretory influx of ions into CSF greatly exceeds the reabsorptive ion efflux from the ventricles; consequently, the net formation of CSF. Ion transporters and channels in the brush border include those for Na
++ and Mg ++ that operate in the processes of CSF formation and homeostasis (Damkier et al., 2013) . Choroid plexus microvilli have a major impact on apical surface area, and thus the capacity to transport. Using stereology on electron micrographs, Keep et al. estimated an apical surface area-to-epithelium volume ratio of~3.3 μm 2 /um 3 in the rat (Keep and Jones, 1990; Keep et al., 1986) , i.e.,~30 fold greater than expected from a 10-μm cuboidal cell with no microvilli. This equates to a total apical surface area of 75 cm 2 in the rat (Keep and Jones, 1990) , which is~50% of the collective luminal area of the inner wall of cerebral capillaries. Estimates of choroidal apical surface area, using electron microscopy, have also been made. Examining a variety of mammalian species, including several primates, Cornford and colleagues found a~10-fold increase in apical surface area due to microvilli (Cornford et al., 1997) . By scaling the rat CP data of Keep and colleagues to human CP (choroid plexus weights of~3 mg and 2 g, respectively), this calculation results in an approximate total apical membrane of 5 m 2 . With the data of Cornford et al.,
the choroidal area is~2 m 2 (Cornford et al., 1997) . Significantly, these more recently-assessed human CP numbers for surface area (2 to 5 m 2 ) are orders of magnitude greater than the 0.02 m 2 described earlier for human CP (Dohrmann, 1970) . Unfortunately, the older, minimal figure of 0.02 m 2 has been repeatedly used in the literature to compare human CP vs. BBB surface area (~10 m 2 ), thereby grossly underestimating the potential importance of CP for CNS transport phenomena (Tang et al., 2014) . Epithelial interdigitations increase the basolateral surface area/volume ratio to~1.1 μm 2 /um 3 in the rat. Moreover, such interdigitations critically amplify areas where local solute concentration gradients (Diamond, 1971) are generated as the 'osmotic-driver' in the CSF secretory process. Apart from electron microscopy evidence, the electrophysiological measurements of cell capacitance also enable an estimate of cell surface area. The surface elaborations (microvilli and interdigitations) increased rat CP epithelial area (apical + basolateral) by~10-fold (Speake and Brown, 2004) . This is similar to the increase in apical + basolateral surface area estimated by Keep and colleagues using a morphometric approach (~7 fold) (Keep and Jones, 1990; Keep et al., 1986) . Altogether, the currently-documented surface area data reinforce the argument for a substantial flux of solutes and water, from plasma through CP epithelium to the ventricles.
Cerebrospinal fluid secretion by CP
The great surface area of the CP external limiting membranes (Smith et al., 2004) (Praetorius et al., 2004) . Apical (Vates et al., 1964) uses ATP substrate to extrude Na + , a process for driving fluid formation and maintaining a Na + transmembrane gradient that facilitates solute transfer into and out of epithelial cells. Carrier-mediated mechanisms export Na + , K + , and Cl − into CSF by way of active transport via the Na (Keep et al., 1994) and electrogenic NaHCO 3 cotransport (sla4a5). Outward diffusion of K + , Cl − , and HCO 3 − from choroid cell into CSF also occurs, i.e., through apical ion channels down their respective electrochemical gradients (Millar et al., 2007) . Consequently, the passive distribution of water into the ventricles osmotically follows the net transport of inorganic ions into CSF, i.e., a dragging effect. Ventricular fluid formation is thus a composite of numerous solute and water translocation phenomena in CP. In humans the continuous formation rate of CSF varies diurnally between 0.2 and 1.0 ml/min, more at night (Nilsson et al., 1994) . Ion trafficking through CP of the BCSFB has been analyzed by radiolabeled tracer transport, autoradiographic mapping, electrophysiologic patch clamping, and with drugs that inhibit/block carriers or − and water, from plasma to epithelial cells to ventricles. Inward movement (secretion) of plasma solutes occurs transcellularly across epithelial cells, by a 2-step sequential process: arrow #1, uptake across epithelial basolateral membrane; and #2, extrusion across apical membrane. Outward movement (reabsorption) of CSF solutes transcellularly is by apical uptake (arrow #3), followed by basolateral release (#4). Less extensive diffusion of substances (due to tight junction resistance) occurs paracellularly between epithelial cells (arrow #5). Specific transporters and channels at respective membranes of choroidal epithelium (see text) are detailed elsewhere (Johanson et al., 2008) .
channels. In the pharmacology category, particularly useful have been diuretic agents that reduce CSF formation by slowing ion transport across CP (Davson and Segal, 1970; Javaheri and Wagner, 1993; McCarthy and Reed, 1974; Murphy and Johanson, 1990; Praetorius and Nielsen, 2006; Johanson, 1980, 1991) . Clearly, the pharmacologic inhibitory linkage in the CP-CSF nexus is consistent with physiologic coupling of CP ion transport to CSF formation. Direct studies have been performed on functionally-isolated lateral CP from which nascent CSF secretions were collected by micropipet (de Rougemont et al., 1960) or from a chamber (Miner and Reed, 1972) . Moreover, the extracorporeal CP preparation in sheep has furnished evidence, by direct fluid sampling, for CSF elaboration (Chen et al., 2010) . Thus, all three abovementioned experiments performed in live animals demonstrated continually-secreted CSF by CP. Furthermore, an in vitro observation, made from measurements of CSF secretion by a monolayer of CP epithelial cells in a transwell, has corroborated the in vivo assessments (Hakvoort et al., 1998) . These independent lines of evidence, i.e., fluid exudates collected directly from secreting apical membranes of different species, preparations and sampling techniques, collectively indicate that CP is a primary source of CSF.
Chemical analyses of isolated choroidal tissue secretions revealed a composition similar to ventricular CSF from animals and humans (de Rougemont et al., 1960; Miner and Reed, 1972 (Davson et al., 1987) . A vascular line of evidence, independent of CSF concentration analysis, has convincingly revealed that CP turns fluid over into the ventricles. The great production of CSF necessitates brisk choroidal blood flow to supply water and ions for epithelial fluid formation. Indeed, the rate of vascular perfusion of the choroid plexuses, i.e.,~4 ml/min/g (Faraci et al., 1990) , is~5× greater than mean blood flow to brain in ml/min/ g. As blood courses through the plexus, the hematocrit increases as fluid in plasma is extracted from the capillary bed; thus, choroidal venous-to-arterial hematocrit is~1.15 (Welch, 1963) . By cinematically observing the transit rate of an injected oil particle, Welch and colleagues determined CP blood flow; then, by combining flow and hematocrit data, they calculated a CP secretion of 0.37 ml/min/g (Welch, 1963) . The figure of~0.4 ml/min/g is similar to estimates in ventricular-cisternal perfusion studies of indicator dilution (Bradbury and Davson, 1964) . Significantly, these collective data indicate that most of the fluid secretion into the ventricles of mammals stems from the CP tissues (Davson et al., 1987) . Moreover, the isolated CP-CSF perfusion system in sheep has produced similar findings (Chen et al., 2010; Thomas et al., 2001) .
Kinetic analyses of uptake of radiolabeled 22 Na and 36 Cl into CSF from plasma provide evidence for CP as a major fluid generator in the CNS. Uptake curves, i.e., the volume of distribution of 22 Na or 36 Cl into CSF as a function of exposure time (integrated plasma concentration of radiolabeled ion) reveal by a curve 'stripping' procedure both a fastand slow-component of CSF uptake. The fast-component or major flux of Na + and Cl − uptake by CSF is via CP because it is inhibited by acetazolamide, which interferes with CP ion transport (Smith and Johanson, 1980) . Interestingly, acetazolamide does not inhibit tracer Na + and Cl − permeation at the BBB in fronto-parietal cortex (Murphy and Johanson, 1989; Smith and Rapoport, 1986) because the cerebral capillaries lack the copious carbonic anhydrase activity that drives ion and water movement across BCSFB. Moreover, the fast-component of 22 Na and 36 Cl across CP is not found in infant rat CSF (Smith et al., 1982) where CP active Na + secretory mechanisms and carbonic anhydrase-generating HCO 3 − are at smaller capacities (Johanson et al., 1992; Parmelee and Johanson, 1989) . The smaller slow-component of CSF Na + and Cl − uptake in adults may be due to paracellular diffusion between CP epithelial cells or to ion penetration at extra-choroidal sites of fluid formation. Autoradiography is useful in tracking movements of solutes, e.g. radiolabeled ions and micronutrients, among anatomical compartments in CNS. 14 C-ascorbate, administered intravenously, was shown by autoradiographic mapping (Hammarstrom, 1966) to penetrate rapidly via carrier into CP and then distribute extensively throughout the ventricles and surrounding ependymal and periventricular brain regions; and, later, deep into brain substance from the CSF (Spector, 1981; Spector and Greene, 1977) . In contrast, there was concurrently negligible permeation of plasma 14 C-ascorbate across BBB to various cortical regions. An autoradiographic approach was also used to track early movement (0-30 min) of carrier-mediated 22 Na and 36 Cl across CNS barriers after intravenous loading (Smith and Rapoport, 1986 ). An autoradiographic pattern of distribution resembling 14 C-ascorbate (Hammarstrom, 1966) Cl into CSF (Fig. 2) with transfer coefficients of~40 × 10
, corresponding in magnitude to the rat CSF secretion rate (Welch, 1975) ; contrastingly, plasma-borne Cl were~200 times greater at the CP epithelium (BCSFB) than at frontal cortex (BBB). This great difference in plasma ion penetration at the two barriers reflects the fact that saltcontaining fluid throughput at CP, i.e., the predominant CSF-producing organ, is much greater than across brain capillaries.
Rapid transport of 22 Na and
36
Cl across the BCSFB (much faster than at BBB) set up a concentration gradient for these tracer ions, from CSF to brain extracellular fluid, to diffuse from ventricles and cisterna magna into adjacent brain (Fig. 3) . Consequently, brain regions near CSF (such as thalamus and hypothalamus) substantially took up 36 Cl from the ventricles (which received tracer from CP secretion), whereas frontal cortex (distant from CP-CSF) took up far less tracer, i.e., mainly across cortical capillaries (Figs. 2 and 3) . To emphasize the dominant influence of the BCSFB vs. BBB uptake from blood,
Cl movement from ventricles into brain was blunted by acetazolamide-inhibited 36 Cl transport at CP (Fig. 4) . Thus, with CSF formation inhibited by acetazolamide, there was a sharp decrease in the availability of 36 Cl in CSF to penetrate the ependyma and distribute into various brain regions. Acetazolamide (which does not alter BBB ion transport) had the least impact on 36 Cl uptake in cortical regions farthest away from the CP tissues that were pharmacologically inhibited. Collectively, the uptake kinetics of 22 Na and 36 Cl, i.e., the 'surrogate' osmotic (salt) markers for accompanying water movement (Smith and Rapoport, 1986) , constitute compelling evidence that ventricular CSF (99% water) derives mainly from CP rather than distant cerebral microvessels.
In addition to physiologic transport and biochemical enzymatic evidence, there is anatomical and biophysical support for CP as the site that actively forms CSF. Cultured monolayers of choroid epithelial cells, inserted in trans-wells as a sheet between compartments corresponding to the basal and apical fluid environments, enable experimental analyses of molecular and biophysical properties. Accordingly, the structural polarization of plasma-and ventricle-facing membranes of the CP epithelium allows segregation of transporter arrays that effect CSF homeostatic transport and secretory phenomena. Such in vitro transport studies show a net flux of solutes for CNS homeostasis, e.g., vitamins and ions, from the basal to apical surface, and the unidirectional secretion of CSF across the epithelial ventricular face (Angeletti et al., 1997; Angelow et al., 2003; Hakvoort et al., 1998) .
A significant biophysical phenomenon associated with CSF formation is that the CP epithelial cell monolayer in culture secretes a column of fluid from the apical membrane that is several centimeters in height. The ability of isolated CP to elaborate fluid against a considerable hydrostatic pressure, i.e., an appreciable fluid column above the trans-well chamber (Hakvoort et al., 1998) , is direct evidence for activelysecreted CSF. The aforementioned biochemical and biophysical evidence for active fluid formation in the CNS is unique for CP, in that comparable phenomena have not been described for BBB and ependymal interfaces. Overall, these data show that ventricular fluid originates preponderantly from CP, not mainly from brain capillaries as maintained by some (Oreskovic and Klarica, 2010) . Choroidally-derived CSF is unequivocally, then, a large component of the ventricular fluid flowing down the traditionally-recognized drainage pathways (Johanson et al., 2008) . CSF-injected dyes/markers reveal rapid bulk flow from lateral ventricles or subarachnoid space, to exit sites at the arachnoidal interfaces with venous sinuses, and nasal submucosa into deep cervical lymph (Johnston et al., 2004 (Johnston et al., , 2005 Kapoor et al., 2008; Pollay, 2010) . Rapid CSF flow down the neuraxis is seen from distribution of radiolabelled-peptides and -nonelectrolytes, convected within minutes to hours from lateral ventricles to subarachnoid regions including Virchow-Robin spaces, as well as cranial/spinal nerve root drainage sites (Bradbury and Cole, 1980; Ghersi-Egea et al., 1996; Nagaraja et al., 2005; Proescholdt et al., 2000) .
Is there also a significant extrachoroidal source of CSF-like fluid? Cerebral capillaries (BBB), the ependymal wall (Pollay and Curl, 1967) , the pia-glia, and the subarachnoidal arterioles and veins are candidate sites but with minimal documented evidence (Davson et al., 1987) . Studies of CNS water flux and exchange, in normal and pathologic states (Buishas et al., 2014) , are important in considering alternative or extrachoroidal sites of fluid formation. As noted above, pioneering studies (Sweet et al., 1950) demonstrated that heavy water (deuterium oxide) rapidly penetrates from blood into brain and CSF of humans many times faster than CSF formation. Similarly, Oldendorf showed that, in one pass of the circulation through rat brain, most plasma water exchanges with the brain and CSF water. Water flowing rapidly out of a cerebrovascular bed on the arterial side may then be readily reabsorbed, due to a greater downstream capillary osmotic pressure, at the venous side of that capillary bed; as a result, there would be no net active formation of fluid in the brain interstitium such as occurs with CSF in the ventricles. Allusion has been made to CSF formation by brain capillary endothelium (Bateman and Brown, 2012) , but there is no clear evidence for this; accordingly, the term 'CSF formation' should be reserved for the product of CP epithelial cells. To reiterate, the prolific brain capillary water turnover (Brinker et al., 2014 ) (with no known net formation of fluid within the interstices) is distinctly different from active transport-linked, carbonic anhydrase-catalyzed, salt-containing CSF formation by CP epithelium (Johanson et al., 1992) . There is longstanding recognition that CP is the source of energy-requiring CSF formation and pressure generation in the ventricles (Netsky and Shuangshoti, 1975) , and modern physiologic and molecular techniques continually substantiate this concept (Damkier et al., 2013; Millar et al., 2007) . Cl activity in rat plasma and CNS regions following i.v. injection of tracer. Note logarithmic scale on y-axis. The CSF uptake curve (flux across CP) is distinguished by relatively rapid uptake from plasma, with which it nearly equilibrates. In contrast, 36 Cl uptake by frontal cortex (distant from CP) is substantially less due to slow permeation of tracer across BBB. The thalamic-hypothalamic region had intermediate uptake of Cl, receiving some tracer across BBB but an additional fraction from CSF via ion transport across CP tissues into ventricles. With permission, from Smith and Rapoport (1986) . Cl actively transported across CP as CSF formation. FC, frontal cortex; PC, parietal cortex; OC, occipital cortex; HC, hippocampus; OB, olfactory bulb; CN, caudate nucleus; TH, thalamus; MB, mid-brain-colliculi; CR, cerebellum; PM, pons-medulla; SC, spinal cord. With permission, from Smith and Rapoport (1986) . Surprisingly, Oreskovic and Klarica (2010) concluded that most saltcontaining ventricular fluid does not derive from CP but rather derives from cerebral capillaries in the brain. Certainly, as discussed above, there is rapid and diffusive exchange of H 2 O between blood, brain and CSF. However, Oreskovic and Klarica do not address the overwhelming evidence for actively-secreted CSF by CP, i.e., a fluid composed of salts, vitamins, hormones and proteins; significantly, the active elaboration of CSF has been the classical view for six decades. The Oreskovic model, thus minimizing the role of fluid generation at the BCSFB interface, was built partly from data obtained largely from ventricular-cisternal perfusions and cerebral aqueduct catheterization in adult cats where negligible CSF flow was found; insufficient data were presented on their anesthetized, heavily-instrumented preparations, e.g., were their experimental animals controlled for temperature, blood pressure and osmotic pressure? Extraordinary new theories, e.g. that CP does not preponderantly secrete CSF, require extraordinary new evidence.
On the other hand, there is substantial evidence from earlier wellcontrolled ventricular-cisternal perfusions (in rats, rabbits and cats) for intraventricular CSF formation and flow down the aqueduct (Davson et al., 1987) . For example, perfusion experiments in 35 cats generated unequivocal evidence that CSF is made in the ventricles but not the subarachnoid space (Lorenzo and Snodgrass, 1972) . In each cat, they performed ventricular-subarachnoid (VS) perfusion followed by ventricular-cisternal (VC) perfusion, using 131 I-labeled albumin (mw 68,000) as the perfusion fluid indicator for dilution to reflect net CSF formation. That no CSF formation was found in the subarachnoid space (Lorenzo and Snodgrass, 1972) counters the argument of Oreskovic and Klarica (2010) that the indicator dilution technique is artefactual (Oreskovic and Klarica, 2014a) due in part to loss of indicator from perfusion fluid to brain. If the latter were true, in the 1972 study by Lorenzo and Snodgrass where the surface area of CSF-contacting brain (ependyma plus pia) in the VS perfusions was~3× that of the VC perfusions, one would have expected much more apparent (calculated) CSF production in the VS experiments than in the VC perfusions alone. In actuality, there was no detected production of CSF in the subarachnoid spaces (that lack CP tissues). These data conclusively show: i) the absence of CSF formation in the cat subarachnoid space, and ii) the reliability of the indicator dilution methodology with albumin. Moreover, multiple MRI studies in adult humans have consistently found net CSF flow down the aqueduct (Bateman and Brown, 2012) .
Another matter being challenged is whether CSF is actively secreted mainly by CP Klarica, 2010, 2014b) . For many decades, there has been widespread agreement that CP epithelium translocates ionic salts (e.g., KCl, and NaHCO 3 ) and that water is entrained ("dragged along") into the ventricles. This substantial energy-requiring choroidal fluid production is unique to the BCSFB, when compared to its absence or much smaller active fluid-making (ion-transporting) capacity at other CNS transport interfaces. Indeed, tracer kinetic analyses have quantified (Smith and Rapoport, 1986 ) that NaCl in CSF has penetrated largely from the blood via CP, rather than across cerebral capillaries which are 2 to 3 orders of magnitude less permeable to plasma Na + and Cl − (Fig. 2) .
Furthermore, Oreskovic and Klarica (2010) do not address much of the information cited above: CP sla4a5 KO mice with CSF diminution, patients with CP hyperplasia and overproduction of CSF cured by CP extirpation, the CP as a fluid secretory organ, etc. In over a decade no one has reproduced their unexpected finding that in adult cats no CSF flows down through the aqueduct of Sylvius (Oreskovikic et al., 2005) . Still, it is possible that the brain actively makes small amounts of a saltcontaining fluid similar in composition to CSF, e.g. at the BBB (Cserr, 1988) ; however, there is scarce evidence, especially for humans, that the BBB rather than CP actively forms most of the salt-containing CSF in the mammalian ventricles.
A new MRI technique (JJVCPE imaging) allows the monitoring of water flux from blood into the CSF compartment. When applied to mice in which AQP-1 or AQP-4 was knocked out, Igarashi et al. measured water influx into the 3rd ventricle (Igarashi et al., 2014) . These data showed that AQP-4 (outside the CP) facilitates unidirectional water flow into the ventricles but AQP-1 knockout mice were no different than controls. The results with AQP-1 are entirely expected since for decades unilateral water influx from blood into the ventricles has been known to be independent of AQP-1, as noted above, since there is no AQP-1 in brain capillaries and basal CP epithelium. The relevance of these results in mice to humans is unknown. In view of the limited blood flow through CP as opposed to the brain, it is likely (but quantitatively unknown) that a substantial portion of the exchange of water between blood and ventricles comes from the brain capillaries surrounding the ventricles. In summary, it is clear that what Igarashi et al. (2014) measured is water influx into the third ventricle, not CSF production, since little CSF is formed in the short time frame of these experiments and, as noted above, water fluxes (exchange) into CSF and brain are orders of magnitude more than CSF production.
Exactly where and how water is osmotically dragged through CP in CSF production is uncertain but apical AQP-1 may play a small role. In this regard, Zeuthen and colleagues have described two pathways of water movement across CP, one passive (channels) and the other mediated by water cotransport with K + and Cl − in the ventricular (CSF-facing) membrane (MacAulay and Zeuthen, 2010; Zeuthen, 1994) . A plethora of evidence, then, procured by a variety of techniques and preparations, abundantly clarifies that CP continuously secretes CSF, a salt solution, into the cerebral ventricles (Johanson et al., 2008) . In humans there is a clear diurnal pattern (Nilsson et al., 1992) . Vigorous choroidal blood flow, together with the activities of key transport enzymes -Na + -K + -ATPase and carbonic anhydrase -drives the CPmanufactured CSF (containing Na
) into the four ventricles (Lorenzo and Snodgrass, 1972) . Transcriptome analysis of Na-K-ATPase isoforms and carbonic anhydrase 2 in rat CP, both integral to CSF formation, reveals that these key transport enzymes appear (mRNA) in embryonic life (Liddelow et al., 2013) ; and thereafter their expression is augmented postnatally as CSF formation and pressure continuously rise to the adult level. It is impressive that CP can actively secrete CSF even when a substantial hydrostatic pressure is exerted on choroidal cells, either perpendicular to the epithelium as a monolayer in a transwell in vitro or when freely suspended in the ventricles under elevated intracranial pressure in situ (as in hydrocephalus).
The model presented by us reinforces the classical thinking of CP-CSF function introduced by Davson and Welch, whereby CP secretes CSF that flows down the ventriculo-cisternal-subarachnoid space axis (Davson et al., 1987) ; this traditional bulk flow model complements the welldocumented concurrent molecular exchanges (including water) between CSF, interstitial fluid and brain capillaries. Thus, the recent attention to brain microvessel/capillary phenomena helps to relate understanding of water/solute dynamics at the BBB to that at the BCSFB (Bateman and Brown, 2012; Brinker et al., 2014) . In line with CP as the chief source of CSF, our model also explains how removal/ablation of CP tissue by surgery/cauterization relieves elevated ICP/ventriculomegaly due to hyperplasia, papilloma or CP carcinoma that overproduce CSF (Hallaert et al., 2012) ; or to obstructive hydrocephalus, e.g., aqueductal block of CSF flow, and relative overproduction of CSF due to obstructed effluence across drainage sites (Warf et al., 2012) . Moreover, recent modeling shows that some cases of communicating HC are due to choroidal overproduction of CSF (Bateman and Brown, 2012) .
Efflux (reabsorptive) transport function of CP
Years ago, the CP was seen mainly as a diffusion barrier to CSF entry. In some cases, this remains true; but since the 1970s, scores of examples have emerged to invalidate that notion as a general principle. Accordingly, discoveries of numerous efflux and influx transporters as well as drug metabolizing enzymes in CP have led to a more complex perspective (Spector and Johanson, 2010) . These transporters have roles in regulating concentrations of endogenous molecules such as phosphate and prostaglandins (Nigam et al., 2015) , and can also be very significant clinically, as exemplified below. For a given molecule or drug, in order to evaluate its net transport into CSF, it is essential to know its influx rate relative to its efflux rate at the BCSFB. The efflux (reabsorptive) rate can be very substantial, thereby preventing a drug, once transported into CSF, from attaining a sufficiently high therapeutic concentration in CSF.
Case report of meningitis (observed by RS)
In 1969, a 19-year-old healthy Iowa recruit undergoing basic training in California (before being sent to Vietnam) developed malaise, fever and was admitted at 5:00 pm. Later, an observant nurse noted skin petechiae. Blood cultures were obtained and the patient was begun on 2 g a day (in divided doses) of cephalothin, intravenously, by the physician on call. That evening, the patient developed a stiff neck; a lumbar puncture showed many white cells in the CSF and a few "cocci." The next morning, the stuporous patient was switched from cephalothin to penicillin 30 million units per day (~30 g of intravenous penicillin G in divided doses) by a senior experienced clinician. Unfortunately the patient died within 48 h of admission for meningococcal disease. Why -since he was started on an antibiotic to which his bacteria were sensitive -did he die?
The answer became scientifically clear several years later when it was established that an efflux transport carrier (now termed organic acid transporter 3-OAT3) in the CP (and also to a lesser extent at the BBB) transports penicillin and similar antibiotics (e.g., cephalothin), both in vitro and in vivo, out of CSF and brain. In vivo, the efflux-rate of penicillin out of rabbit CSF is fourteen times greater than the influx rate (Spector, 2010) . This is the main reason that the steady-state penicillin G concentration in CSF in rabbits and humans is only~1% that in plasma. OAT3 has been cloned, expressed and characterized; and is present in large amounts on the apical surface of CP (Angeletti et al., 1997) and on the abluminal side of BBB capillaries in animals and humans (Spector, 2010) . Thus to be effective in the therapy of meningitis, the penicillin and other drugs pumped out of CSF must be given in massive parenteral doses (to saturate the removal mechanism, thus allowing more drug to remain in CSF); or antibiotics like imipenem or ceftriaxone (that are not pumped out of CSF by CP) must be employed (Spector, 1986) . Ceftriaxone is now the drug of choice for many patients with bacterial meningitis. Standard doses of penicillin (or drugs like cephalothin) are ineffective in meningitis since they are pumped out of CSF and, since time is of the essence, must not be used. Would the aforementioned patient have survived if mega-dose penicillin had been started earlier? This is not knowable retrospectively but his prospects for survival would have been better.
Another well-characterized system, the oligopeptide transporter PEPT2, resides on the apical surface of CP and also clears some antibiotics from CSF (Shen et al., 2007; Spector, 2010) . PEPT2 transports cephalosporins with an α-amino group, such as cefradoxil. Thus, CSF cefradoxil concentrations are much lower than plasma concentrations after systemic administration. Experimentally, CSF cefradoxil concentrations are markedly increased in PEPT2 KO mice (Shen et al., 2007) . Accordingly, cephalosporins containing α-amino groups are not used to treat meningitis.
Multiple other efflux carriers exist in CP that substantially alter the reabsorptive flux from CSF of many drugs, and natural substances, e.g., choline (Sweet et al., 2001) ; this is inconsistent with the old notion of molecular weight, ionic change and lipid solubility mainly determining the molecular distribution between CSF and plasma. The reader may wish to consult the many excellent reviews and books on efflux transport out of CSF via CP (Spector and Johanson, 2010; Spector, 2010; Davson et al., 1987) .
Non-ionic influx transport function of CP
For decades it has been recognized that the earlier notion of the CP as "nourishing liquor" has some, although, limited merit. For example, the CP (not the capillaries at the BBB) transfers folate and vitamin C through the blood-CSF barrier to achieve a four times higher concentration in CSF (Spector, 2009) . From CSF, the vitamins readily enter brain across the permeable ependyma and pia-glia. The importance of these systems is seen in patients with mutations of the proton-coupled folate transporter (PCFT) or the folate receptor alpha (FRα), both transport proteins being involved in translocating folate through CP from blood into CSF. Not only do these patients have low folate in the CSF but also they develop devastating neurological disorders, and even death, unless treated with massive doses of folates (Spector, 2014; Spector and Johanson, 2014) . CP also transports other peptides from blood into CSF, e.g., prolactin and leptin (Thomas et al., 2001) . Recent treatises of the multiple influx, e.g. insulin-like growth factor-I (Carro et al., 2005) , and secretory functions of CP are available (Damkier et al., 2013; Smith et al., 2004; Spector, 2009) .
To recapitulate, the earlier notion that the molecular size, charge and lipid solubility of many drugs, nutrients and certain proteins are the principal factors determining passive distribution of many substances between the CSF, brain and blood, has been supplanted with a more active, multi-transporter regulated view of the BCSFB. Moreover, the active transport systems for these compounds are clinically relevant in some cases as per the clinical example above. In fact, many such examples of carriers are now known to transport drugs in the treatment of AIDS (Varatharajan and Thomas, 2009 ), cancer and other disorders. Similarly there are transporters at the BBB, such as P-glycoprotein (Cirrito et al., 2005) , that in cooperation with the CP protect the CNS or in other cases, e.g. the GLUT-1 transporter (Farrell et al., 1992) , provide glucose to nourish the brain (Spector, 2009; Spector and Johanson, 2010) .
Penetration of substances from the CSF into the brain
There has been some reluctance in the CSF field, even recently (Tang et al., 2014) , to accept the idea that solutes can penetrate deeply into the brain from the ventricles. This notion, also needing revision, has arisen from data obtained in acute ventricular perfusions or injections (a few hours) wherein the test substance was rapidly actively reabsorbed or, even if not actively removed, swept away by bulk flow (not having adequate time to diffuse deeply into brain from a significant concentration 'point source' in ventricular CSF) (Nagaraja et al., 2005) .
Based on a few examples, Pardridge (2012) suggested that small molecules including drugs do not penetrate significantly from the CSF into the brain, e.g., after transfer by CP from the blood into the CSF or by direct injection into the ventricles. He used lipid-soluble substances and methotrexate as examples. It is true that lipid-soluble substances readily traverse biological membranes and methotrexate, a watersoluble compound, leaves CSF rapidly. However, methotrexate, we now know, is pumped out of the CSF and brain by specific barrier transporters (Ohtsuki et al., 2003) and, in fact, makes the case prototypically for transporters determining drug distribution, not just passive forces. A similar situation exists with leucine which is also removed, by a saturable amino acid carrier, out of the subarachnoid space (Lorenzo and Snodgrass, 1972) and ventricular CSF.
In actuality, though, some molecules in CSF can penetrate deeply into the substance of the brain. This was shown in 1966 with vitamin C in mice (Hammarstrom, 1966) , later with sucrose in cats (Lorenzo and Snodgrass, 1972) , and later still with mannitol and vitamin C in rabbits (Spector, 1981) . The process of brain penetration of molecules is slow -days, not hours and there is some diurnal variation. Subsequently, as noted above, NaCl and even inulin (mw~5000) were shown to gradually enter the deep substance of the brain from CSF via diffusion and propulsion (convection) by the dynamic arterial pulsations in the brain/CSF visible by micro-video probes in the ventricles. It is worth noting that sucrose (mw 360), mannitol (mw 180) and inulin, unlike vitamin C, are all passively distributed in the CNS, mainly in the CSF-extracellular space of the brain (Johanson, 1980; Lorenzo and Snodgrass, 1972; Spector and Johanson, 2014) . Although not known quantitatively, a major proportion of the NaCl in the extracellular space of brain comes from the CSF via active transport across CP, not directly through the BBB (Smith and Rapoport, 1986) . Overall some ions, micronutrients and drugs (not actively reabsorbed by CP or the BBB) can penetrate deeply into brain from ventricular CSF.
Extirpation of CP
Several decades ago, Klosovskii showed that 'complete' extirpation of CP in neonatal dogs led to deficient brain development and function (Klosovskii, 1963) . Because damage to the canine brains occurred during the choroid plexectomies, these and other similar experiments cannot be considered definitive. However, we now know that eradication of just one function in CP, e.g., folate transport by KO of either PCFT or FRα in humans, leads to severe neurological disease or death as discussed above (Spector, 2009 (Spector, , 2014 Spector and Johanson, 2014) .
This raises a question about the long-term effects of extirpating the two lateral CPs as a treatment for absolute or relative overproduction of CSF in hydrocephalus (Pliushcheva and Shakhnovich, 1994 ) -either the communicating or obstructive type. Without doubt, in many cases where shunting is neither feasible nor performed, lateral CP extirpation seems to "work" with amelioration of the signs and symptoms of hydrocephalus (Bateman and Brown, 2012; Hallaert et al., 2012; Warf et al., 2012) . The improvement mechanism is clear. Removal of the lateral CP tissues decreases total CSF production, in many cases presumably by~50% (lateral ventricle CPs are~1/2 the total CP mass), thereby reducing the volume and relieving the pressure in the ventricular system. Moreover, it is formally possible that there will not be long-term consequences to brain structure and function (by analogy with the removal of one of the two kidneys) since~50% of CP tissue is not removed. However, this hypothesis needs to be tested rigorously in carefully-controlled trials over extended time periods, e.g. against third ventriculostomy or shunting (Souweidane, 2014; Stone and Warf, 2014) .
Conclusions
In summary, the CP of mammals and humans is a generouslyperfused organ in the brain with an enormous surface area. The CP secretes most of the CSF that contains nourishing molecules, e.g., vitamins and transthyretin, able to penetrate from CSF deep into the substance of brain (Damkier et al., 2013; Spector, 2009) . Moreover, the CP also pumps out of CSF many clinically important drugs such as penicillin, and polarized endogenous and exogenous endogenous molecules not needed by the brain (Miller, 2004; Spector and Johanson, 2013) . Not only does the CP manufacture CSF for the brain, e.g., for buoyancy protection against physical blows, but also it provides continuous and fresh CSF for brain ion and molecular homeostasis. Without CP and its vital CSF transport systems, e.g. for folate and vitamin C (Spector and Johanson, 2014) , the brain cannot live.
